Here we present a case report of a chronic lymphoblastic leukemia-related pancytopenia patient where after treatment with Cyclosporin-A, chronic lymphoblastic leukemia has effectively remitted. To further understand the effect of Cyclosporin-A in immune micro-environment reconstruction and its anti-leukemia potential.